Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023
17 avr. 2023 16h15 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, April 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators,...
Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report
28 mars 2023 17h00 HE
|
Maravai LifeSciences Holdings LLC
- Highlights progress across five priority areas focused on building a foundation for sustainable growth. - Reports Scope 1 and Scope 2 greenhouse gas emissions. - Maravai advances Diversity, Equity...
Maravai LifeSciences Announces March 2023 Investor Conference Schedule
08 mars 2023 08h00 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled...
Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results
22 févr. 2023 16h05 HE
|
Maravai LifeSciences Holdings LLC
Base business revenues, excluding COVID-19 related CleanCap® revenues, were up 67% in the fourth quarter and up 17% for the full year Announces acquisition of privately-held Alphazyme, LLC, adding...
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
01 févr. 2023 08h00 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans...
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
01 déc. 2022 16h01 HE
|
Maravai LifeSciences Holdings LLC
Maravai announces plans for William “Trey” Martin, III to serve as President of its Biologics Safety Testing Segment and its expectation that he will then assume the role of Maravai’s CEO in July 2023...
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America
16 nov. 2022 17h05 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced...
New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing
07 nov. 2022 16h10 HE
|
Maravai LifeSciences Holdings LLC
SOUTHPORT, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and services provider for the detection and...
Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule
03 nov. 2022 16h05 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to...
Maravai LifeSciences Reports Third Quarter 2022 Financial Results
02 nov. 2022 16h05 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...